Answers are grounded in this paper and cite their sources.
In this paper, we measured B cell function in elderly healthy individuals (E H ) and in elderly patients with Type-2 Diabetes Mellitus (T2DM, E T2DM ), which are treatment-naive, as compared to healthy young (Y H ) individuals. Results show a higher serum inflammatory status of elderly versus young individuals, and especially of E T2DM versus E H . This status is associated with a reduced response to the seasonal influenza vaccine and with increased frequencies of the circulating pro-inflammatory B cell subset called Double Negative (DN) B cells. B cells from E T2DM patients are not only more inflammatory but also hyper-metabolic as compared to those from E H controls. The results herein are to our knowledge the first to show that T2DM superimposed on aging further increases systemic and B cell intrinsic inflammation, as well as dysfunctional humoral immunity. Our findings confirm and extend our previously published findings showing that inflammatory B cells are metabolically supported.
No takes yet. Share an insight, caveat, or question.
Frasca et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: